Medicine
-
Redesigned CD40 Antibody Shrinks Tumors in Half of 12 Patients in Early Rockefeller Trial
A locally injected, Fc-optimized CD40 agonist shrank tumors in half of 12 patients, including two complete remissions, after…
Most read
-
Falkland Islands Today: Population, Economy, and Military Presence
-
Viktor Orbán’s 16-Year Rule Ends in Landslide Defeat and Constitutional Exile
-
Tony Blair warns Green Party’s ‘Zionism is racism’ vote signals dangerous normalization
-
Red Sea crisis: Houthi attacks hit 178 ships, sinking four and killing nine sailors
-
Sudan’s Drone War Deepens Humanitarian Crisis with Civilian Toll and Displacement
-
U.N. Nuclear Watchdog Urges Access to Isfahan Facility as Trump Dismisses Need for Deal
-
Sanctions Fail to Stop Sudan’s Conflict Gold Trade, New Research Finds
-
Trump Envoys Witkoff Kushner Meet Putin In Moscow For Ukraine Ceasefire Talks
-
Israeli Strike on Gaza Hospital Kills Six as Ceasefire Violations Mount
-
Oleksandra Matviichuk Champions International Justice Mechanisms for Ukrainian Victims
-
India’s Decision to Let Ganges Water Treaty Expire Raises Risk of Bilateral Tension with Bangladesh
-
Jared Kushner Navigates Complex Diplomacy to Expand Ukraine Peace Talks
-
How World Food Programme Funding Cuts Are Threatening Sudan Aid Operations
-
Why Dozens of Nations Are Demanding More Aid for Gaza Amid Winter
-
How South Africa’s Mercenary Laws Constrain Foreign Fighters
-
How Russia’s Seizure of Crimea in 2014 Reshaped Europe’s Security Order
-
From the Navigation Acts to Opium: how trade disputes led to war
-
Iranian Attacks on Kuwait Power, Water Plants Enter Fourth Day
-
Zelensky Dismisses Army Chief Syrskyi After Protests and Names Drapatyi
-
Russia Replaced Soviet Regiments With Brigades That Field Battalion Tactical Groups